Get UpLyfted With Restylane Lyft
Natural-Looking Volume & Definition For Your Cheeks
Restylane® Lyft is now approved by the FDA for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21. This is in addition to treating moderate-to-severe facial wrinkles and folds, such as nasolabial folds (smile lines).
What Is Restylane Lyft?
As we age and our faces lose volume, some of us begin to look for ways to regain more definition in our cheeks without surgery. Restylane Lyft, formerly known as Perlane-L®, is an injectable hyaluronic acid gel used to correct volume loss and treat wrinkles in the face.
Restylane Lyft is the first and only FDA-approved filler indicated to provide lift to cheeks and add volume to correct and smooth smile lines (nasolabial folds).
How does Restylane Lyft Work?
Over time, the natural fat that surrounds the cheeks begins to deteriorate, resulting in sagging skin, more prominent wrinkles and a reduction of volume. Through nonsurgical injections, Restylane Lyft is specifically designed to add fullness to the cheeks and midface area, which can result in a more natural-looking, youthful appearance.
Important Safety Information
Indications: Restylane® Lyft with Lidocaine is indicated for implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds, and for subcutaneous to supraperiosteal implantation for cheek augmentation and correction of age-related midface contour deficiencies in patients over the age of 21.
Restylane Lyft with Lidocaine should not be used by people with severe allergies, particularly to microorganisms known as gram-positive bacteria, or by people with serious allergies to drugs that have previously required in-hospital treatment. This product should not be used by people with bleeding disorders and should not be injected anywhere except just under the skin. Restylane Lyft with Lidocaine should not be used in people with a known allergy to lidocaine.
The most common adverse events after initial treatment include bruising, redness, swelling, pain, headache, tenderness, and itching. Use at the site of skin sores, pimples, rashes, hives, cysts, or infection should be postponed until healing is complete. In these instances, product use could delay healing or make skin problems worse.
This product should not be injected into the blood vessels as it may cause vascular occlusion, infarction, or embolic phenomena.